Table 1 AIF group: PET study indication and population demographics
Number of patients | Age distribution* | |||||
|---|---|---|---|---|---|---|
Scan indication | Total | Male | Female | Total | Male | Female |
Breast cancer | 1 | 0 | 1 | 62 | – | 62 |
Cancer of unknown primary origin | 1 | 0 | 1 | 58 | – | 58 |
Gastro-intestinal cancer | 3 | 0 | 3 | 57 [49–66] | – | 57 [49–66] |
Gynaecological cancer | 2 | 0 | 2 | 65.5 [58–73] | – | 65.5 [58–73] |
Infection & inflammation | 3 | 2 | 1 | 51.7 [30–67] | 62.5 [58–67] | 30 |
Lung cancer | 4 | 3 | 1 | 69.8 [56–78] | 67 [56–76] | 78 |
Lymphoma | 6 | 4 | 2 | 56.3 [29–77] | 62 [46–77] | 45 [29–61] |
Total | 20 | 9 | 11 | 59.7 [29–78] | 63.8 [46–77] | 56.4 [29–78] |